Aug 11, 2023 / 03:30AM GMT
Saurabh Paliwal - Biocon Limited - Head of IR
Good morning, everyone. I'm Saurabh Paliwal from Biocon's Investor Relations team. And I would like to welcome you to Biocon's earnings call for the first quarter ended June 30, 2023. (Operator Instructions)
Please note that the chat box is disabled, but you can raise any technical concerns by sending us an e-mail to [email protected].
I would also like to bring to your attention that this conference call is being recorded. The recording will be available on our website within a day, and the transcript will be made available subsequently.
Today, to discuss this quarter's business performance as well as the future outlook for the company we have Dr. Kiran Mazumdar-Shaw, our Executive Chairperson, and other senior leaders from different businesses, including Biocon Generics, Biocon Biologics and Syngene.
I would like to also take this opportunity to remind everyone related to the safe harbor for this call. Comments made during this call may be forward-looking in nature based on management's current beliefs and
Q1 2024 Biocon Ltd Earnings Call Transcript
Aug 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers